Home

Hubert Hudson Honteux Violon nik kinase pasteur fille médias

The non-canonical NF-κB pathway in immunity and inflammation | Nature  Reviews Immunology
The non-canonical NF-κB pathway in immunity and inflammation | Nature Reviews Immunology

Promega ADP-Glo Kinase Assay + NIK Kinase Enzyme System 1 each:Cell  Analysis | Fisher Scientific
Promega ADP-Glo Kinase Assay + NIK Kinase Enzyme System 1 each:Cell Analysis | Fisher Scientific

IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity,  Inflammation, and Cancer
IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer

Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small  molecules for the treatment of human diseases - RSC Medicinal Chemistry  (RSC Publishing)
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing)

Schematic representation of Nuclear Factor-κB (NF-κB)-inducing kinase... |  Download Scientific Diagram
Schematic representation of Nuclear Factor-κB (NF-κB)-inducing kinase... | Download Scientific Diagram

NIK (human) (326-686)
NIK (human) (326-686)

Anti-NFkB Inducing Kinase NIK antibody (ab228587) | Abcam
Anti-NFkB Inducing Kinase NIK antibody (ab228587) | Abcam

Negative Feedback in Noncanonical NF-κB Signaling Modulates NIK Stability  Through IKKα-Mediated Phosphorylation | Science Signaling
Negative Feedback in Noncanonical NF-κB Signaling Modulates NIK Stability Through IKKα-Mediated Phosphorylation | Science Signaling

Recombinant Human NFkB Inducing Kinase NIK protein (ab61262) | Abcam
Recombinant Human NFkB Inducing Kinase NIK protein (ab61262) | Abcam

NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 | PNAS
NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 | PNAS

Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small  molecules for the treatment of human diseases - RSC Medicinal Chemistry  (RSC Publishing) DOI:10.1039/D0MD00361A
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A

Kinase Selectivity Profiling Systems—STE and TKL
Kinase Selectivity Profiling Systems—STE and TKL

NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine

Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB  (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets

Possible mechanism of the effect of aging and heptadecane on the... |  Download Scientific Diagram
Possible mechanism of the effect of aging and heptadecane on the... | Download Scientific Diagram

Nck-Interacting Ste20 Kinase Couples Eph Receptors to c-Jun N-Terminal  Kinase and Integrin Activation | Molecular and Cellular Biology
Nck-Interacting Ste20 Kinase Couples Eph Receptors to c-Jun N-Terminal Kinase and Integrin Activation | Molecular and Cellular Biology

Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors  That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal  of Medicinal Chemistry
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal of Medicinal Chemistry

NIK Antibody | Cell Signaling Technology
NIK Antibody | Cell Signaling Technology

NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine

NFkB Inducing Kinase NIK Antibody – Bioss
NFkB Inducing Kinase NIK Antibody – Bioss

The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK)  inhibitors with anti-inflammatory effects in vitro, low toxicities against  T cell growth - ScienceDirect
The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth - ScienceDirect

NF-κB inducing kinase is a therapeutic target for systemic lupus  erythematosus | Nature Communications
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus | Nature Communications

NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 | PNAS
NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 | PNAS

NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine

Frontiers | NF-κB Inducing Kinase Regulates Intestinal Immunity and  Homeostasis
Frontiers | NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis

Non-canonical NF-κB signaling pathway | Cell Research
Non-canonical NF-κB signaling pathway | Cell Research

Frontiers | The Therapeutic Potential of Targeting NIK in B Cell  Malignancies
Frontiers | The Therapeutic Potential of Targeting NIK in B Cell Malignancies

Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits  response to Aurora inhibitors in multiple myeloma | Haematologica
Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma | Haematologica